Stategy: sell on the fact of the offer, wait until the Board rejects the offer, if they do so, buy back in on a dip, and await a further offer. I've been in failed takeovers- not pretty.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025